Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 11:34 PM
NCT ID:
NCT02641093
Group ID:
EG000
Title:
Pembrolizumab
Description:
Pembrolizumab in combination with standard of care surgery followed by radiation therapy with or without cisplatin
Pembrolizumab: Pembrolizumab administered one week prior to surgery and then every three weeks in the adjuvant setting for a total of 7 doses.
Surgery: gross total surgical resection
Radiation Therapy: 60-66 Gy over 6 weeks
Cisplatin: Weekly during radiation therapy for 6 doses only for patients with high risk pathological features
Deaths Number Affected:
20
Deaths Number At Risk:
None
Serious Number Affected:
43
Serious Number At Risk:
96
Other Number Affected:
92
Other Number At Risk:
96
Study:
NCT02641093
Results Section:
NCT02641093
Adverse Events Module:
NCT02641093